Drugmaker of cancer medications ignored more than 200 bad quality tests, FDA says
Drugmaker of cancer medications ignored more than 200 bad quality tests, FDA says U.S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U.S. market aborted hundreds of drug-quality tests because they seemed like they were going to fail due to impurities. When workers at the plant found potential […]